BDBM477107 US10888567, Compound 3::US11414428, Compound 1

SMILES Cc1nc2onc(N)c2c(C)c1Cl

InChI Key InChIKey=XEYWCHKONZUDGB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 477107   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Antido Therapeutics International

US Patent
LigandPNGBDBM477107(US10888567, Compound 3 | US11414428, Compound 1 | ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2025
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Antido Therapeutics International

US Patent
LigandPNGBDBM477107(US10888567, Compound 3 | US11414428, Compound 1 | ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Antido Therapeutics International

US Patent
LigandPNGBDBM477107(US10888567, Compound 3 | US11414428, Compound 1 | ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
US Patent